Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Biogen, Inc.
Current Parent CompanyBiogen
Parent at the Time of the Penalty Announcement subscribe to see this data field
Recap of Ownership Changes subscribe to see this data field
Penalty: $22,000,000
Year: 2020
Date: December 17, 2020
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Pharmaceutical company Biogen, Inc. agreed to pay $22 million to resolve claims that it violated the False Claims Act by illegally using foundations as a conduit to pay the copays of Medicare patients taking Biogen's multiple sclerosis drugs Avonex and Tysabri.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: Massachusetts
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.